Broadwater: With glaucoma, our two goals for controlling pressure are either slowing down fluid production or finding an ...
Policymakers and eye-care providers keen to turn India's glaucoma challenge into a global model of sustainable eye care: Our Bureau, Bengaluru Friday, April 10, 2026, 16:15 Hrs [I ...
A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal ...
WASHINGTON— Cyclophotocoagulation, a safe and effective procedure, should be considered by ophthalmologists more often for ...
BL 1107 is a next‑generation, alpha‑2B‑selective prodrug designed to lower IOP and provide neurofunctional benefit—clinical proof‑of‑concept showed IOP lowering plus "15‑letter" visual gains and ...
A 44-year-old woman presented to an outside ophthalmology clinic with significant nausea, blurry vision in the right eye and ...
The Healthy @Reader's Digest on MSN
What I wish I’d known about cataract surgery: A doctor details what patients should know about a common procedure
An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...
In eye clinics and clinical trials, doctors increasingly rely on patients' own reports of how eye disease and treatment ...
Blindness is not inevitable. Many of the leading causes of vision loss can be prevented or treated with early detection and ...
Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the ...
IRIDEX Corporation (NASDAQ:IRIX) Q4 2025 Earnings Call Transcript March 26, 2026 IRIDEX Corporation beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02. Jordan: Thank you for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results